Upcoming Healthcare Conference Presentation by PROCEPT BioRobotics
PROCEPT BioRobotics is getting ready to captivate the audience at the 37th Annual Piper Sandler Healthcare Conference. This exciting event will take place in New York City, marking an important occasion for the surgical robotics company dedicated to enhancing patient care in urology. The presentation is scheduled for a specific date in early December and is set to begin at 8:30 a.m. Eastern Time. The insights to be shared at this conference could pave the way for breakthroughs in the field of urology.
Live Webcast Availability
For those unable to attend the event in person, a live webcast will be provided, offering valuable access to the presentation. Additionally, an archived recording will be made accessible on the Investors section of the company’s website shortly after the event concludes. This ensures that all interested parties can stay informed about the innovative developments PROCEPT BioRobotics is working on. The archived webcasts will be available for at least 90 days, giving ample time for viewing.
About PROCEPT BioRobotics
PROCEPT BioRobotics has a clear mission: to transform the treatment of Benign Prostatic Hyperplasia (BPH) on a global scale in collaboration with urologists. By providing state-of-the-art robotic solutions, they aim to enhance patient outcomes and overall value. One of their significant innovations is the AQUABEAM and the HYDROS Robotic Systems. The HYDROS system stands out as the only AI-Powered robotic technology delivering Aquablation therapy, designed expressly for men experiencing lower urinary tract symptoms caused by BPH.
Innovative Aquablation Therapy
Aquablation therapy is a cutting-edge treatment approach that ensures effective, safe, and durable results for men affected by BPH, regardless of their prostate's size or shape, or the surgeon's experience. Notably, BPH is a widespread prostate condition impacting around 40 million men in the United States alone.
Clinical Evidence Supporting BPH Treatments
The dedication of PROCEPT BioRobotics to innovation is demonstrated by their growing body of clinical evidence, which includes over 150 peer-reviewed publications. These documents highlight the numerous benefits and clinical advantages that Aquablation therapy offers, reinforcing the company's commitment to patient-centric solutions in urological health.
Contact Information for Investors
For those interested in learning more about PROCEPT BioRobotics or the upcoming presentation, they can reach out to Matt Bacso, who serves as the VP of Investor Relations and Business Operations. He is available via email at m.bacso@procept-biorobotics.com for inquiries related to investment opportunities and company operations.
Frequently Asked Questions
What will PROCEPT BioRobotics discuss at the conference?
They will present their advancements in robotic solutions for urological care and highlight the benefits of their innovative therapy options.
How can I access the live webcast?
The live webcast will be available on the Investors section of the company’s website during the conference.
Why is the HYDROS system significant?
The HYDROS system is revolutionary in that it is the only AI-Powered robotic technology for delivering Aquablation therapy, addressing BPH efficiently.
What impact does BPH have on men?
BPH affects approximately 40 million men in the U.S., leading to significant discomfort and health issues related to lower urinary tract symptoms.
How can I contact PROCEPT BioRobotics for inquiries?
You can contact Matt Bacso, VP of Investor Relations, at m.bacso@procept-biorobotics.com for any investment-related queries.
